IGEN says court decision may free it from Roche
This article was originally published in Clinica
Executive Summary
IGEN International has been granted a decision in the US Federal court, which, the company says, may finally lead to IGEN severing its licence agreement with Roche Diagnostics and leaving it open to take on new licensing partners for its ORIGEN detection technology.